anemia Flashcards

1
Q

how is anemia in CKD defined?

A

HGB < 13 g/dL for males
HGB < 12 g/dL for females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the goals of therapy for anemia of CKD?

A
  1. increase O2 carrying capacity
  2. improve QOL
  3. prevent/alleviate symptoms and complications of anemia
  4. decrease need for blood transfusions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

when does anemia begin to develop?

A

as GFR declines < 45 ml/min/1.73m^2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are some baseline labs to assess in anemia?

A
  1. HGB
  2. serum iron
  3. serum ferritin
  4. transferrin saturation (Tsat)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is ferritin?

A

the storage form of iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is transferrin saturation?

A

reflects the functional iron available for immediate erythropoesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

hepcidin MOA

A

inhibits ferroportin channel that absorbs Fe to be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

do CKD patients have high or low hepcidin and what is the effect?

A

high hepcidin -> hepcidin is excreted by the kidneys so it accumulates in CKD patients
causes iron deficiency since ferroportin stops working due to lots of hepcidin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the most common cause of erythropoietin resistance?

A

iron deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how often should the iron panel be monitored?

A

every 3 months in an ESRD patient and anyone receiving EPO for anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the therapeutic response to iron?

A
  1. increase in reticulocyte count within 7-14 days
  2. increase in HGB and HCT within 3-4 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what must be done prior to initiating an ESA (EPO stimulating agent)?

A

must correct iron deficiency FIRST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the goals of therapy for anemia in CKD?

A

Tsat > 30%
Serum Ferritin > 500 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when and why should IV iron be held?

A

Tsat > 50% or Ferritin > 1200 ng/mL
due to risk of iron overload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how often should HGB and HCT be checked once ESA therapy is initiated?

A

weekly during therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how often should Tsat and serum ferritin be checked?

A

every 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are some disadvantages of oral iron therapy?

A
  • poor absorption
  • GI complications: nausea, constipation
  • poor adherence (<50%)
  • slow replenishment of iron stores
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is an advantage to oral iron therapy?

A

inexpensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are some advantages of parenteral iron therapy?

A
  • better absorption
  • rapid replenishment of iron stores
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are some advantages of parenteral iron therapy?

A
  • better absorption
  • rapid replenishment of iron stores
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are some adverse effects of oral iron therapy?

A
  • GI: nausea, cramping, constipation
  • dark stool
  • MANY DDIs (e.g. calcium carbonate, antacids)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what are some adverse effects of IV iron therapy?

A
  • dyspnea/wheezing, itching, myalgias
  • hypotension, flushing, edema
  • chest pain, cardiac arrest
  • injection site reaction, anaphylactoid and anaphylactic reactions
  • INFECTION!!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

when should we AVOID giving IV iron?

A

in patients with active systemic infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

traditional target oral iron dosing

A

target 200 mg of elemental iron/ day in divided doses
ex: ferrous sulfate 325 mg PO TID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
ferrous sulfate
tablet: 325 mg (65) or 195 mg (39) 20% elemental iron
26
ferric citrate
tablet: 210 mg (210) 100% elemental iron!
27
oral iron DDIs
drugs that decrease iron absorption: - Al, Mg, and Ca containing antacids - tetracyclines - H2 antagonists - PPIs - cholestyramine *oral iron NEEDS gastric acid to be absorbed!* object drugs affected by iron - fluoroquinolones - levothyroxine - tetracyclines - mycophenolate - methyldopa - levodopa *separate administration by ~ 2 hrs!*
28
IV iron formulations
ferric gluconate iron sucrose
29
IV therapy clinical pearls
- IV iron is the preferred therapy in dialysis patients - in NON-dialysis patients: a 1-3 month trial of oral iron can be used -> can convert to IV if no response > 3 months
30
what are the goals of iron therapy in CKD?
Tsat ≥ 30% (limit of 50%) Serum ferritin ≥ 500 ng/mL (limit of 1200 ng/mL)
31
how often should routine monitoring of Tsat and serum ferritin be done?
at least every 3 months
32
epoetin alfa brand name
Epogen
33
dosing of epoetin alfa
either 3 times a week IV OR once weekly SubQ (preferable due to cost saving)
34
darbepoetin alfa brand name
Aranesp
35
dosing of darbepoetin alfa
once a week or every 2 weeks (IV or SubQ)
36
methoxy polyethylene glycol epoetin beta brand name
Mircera
37
dosing of methoxy polyethylene glycol epoetin beta
every 2-4 weeks
38
which is the longest acting ESA?
methoxy polyethylene glycol epoetin beta - can be given up to once a month!
39
MOA of methoxy polyethylene glycol epoetin beta
continuous erythropoietin receptor agonist
40
epoetin alfa epbx brand name
Retacrit
41
dosing of epoetin alfa epbx
3 times a week IV OR once weekly SubQ
42
which ESA is the cheapest?
epoetin alfa epbx -> is a biosimilar of epoetin alfa
43
FDA initiation guideline for ESAs and Hemoglobin targets
initiation of ESA: if < 10 g/dL (ESRD) target HGB: 10-11 avoid transfusions
44
is it normal to give ESA and NOT see any changes in HGB and HCT?
YES -> wait and watch, don't do anything
45
what is the goal change in HGB when starting ESAs?
1-2 g/dL/month
46
when should we dose adjust ESAs after initiation?
4 weeks (steady state)
47
when should we reduce the ESA dose by ≥ 25%?
if patient's HGB approaches 11 g/dL or if HGB increases > 1g/dL in 2 weeks or less!
48
when should we increase the ESA dose by 25%?
if patient's HGB is below target after 4 weeks of treatment
49
when to hold ESA dose in ND-CKD patients?
when HGB > 10
50
when to hold ESA dose in D-CKD patients?
when HGB > 11 (11-12; APPROACHING 12 is when you want to hold)
51
ESA hyporesponsiveness
1. no increase in HGB after first month of appropriately dosed ESA 2. Two ESA dose increases after stable period to maintain HGB
52
ESA resistance
failure to achieve a target HGB at a dose of > 500 units/kg/week (5x starting dose)
53
Causes of ESA Resistance
1. IRON DEFICIENCY!! 2. ACEIs 3. Hyperparathyroidism 4. Aluminum toxicity 5. Folate and/or Vitamin B12 deficiency 6. Infection* 7. Malignancy* 8. Trauma* 9. Inflammation* *decrease bone marrow responsiveness to EPO
54
ESA Adverse Effects
HTN (dose-dependent) Hypercoagulability -> increased risk of thrombosis (DVT, PE, MI, CVA, etc.) Hypersensitivity rxns PRBCA: Pure Red Blood Cell Aplasia Headache, fatigue, edema Progression of malignancy
55
BBW for ESAs in CKD
greater risk of death, serious adverse cardiovascular reactions, and stroke when administered ESAs to target a HGB level > 11 g/dL
56
ESA Monitoring Parameters (initial phase -> maintenance phase)
HCT/HGB: 2x a week -> 1-2x a month BP: 3x a week -> 3x a week Ferritin: monthly -> quarterly TSat: monthly -> quarterly CBC, BUN/Cr, K, Phos: 2x a month -> 1x a month Reticulocytes: 1x a week -> quarterly
57
ESA Clinical Pearls
- these agents do NOT decrease mortality - can be administered IV or SubQ (IV preferred in dialysis and SubQhas longer duration of effect and saves costs) - DO NOT USE IF: active malignancy, high risk of CVA, and HGB > 11 g/dL
58
when are PRBCs given?
packed red blood cells are given when severe anemia occurs (HGB < 7 g/dL) -> rapid correction of O2 carrying capacity
59
every 1 unit of PRBC causes what effect on HGB?
a 1 g/dL increase in HGB
60
1 unit of PRBC contains how much elemental iron?
~ 200 mg
61
at are some risks of blood transfusions?
1. transfusion-related acute lung injury 2. hypervolemia 3. hypocalcemia 4. hypersensitivity rxn 5. immune activation (bad for kidney transplant candidates)
62
Vitamin Supplementation in Dialysis
supplement water-soluble vitamins (B, C, and folic acid)